Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland.
2nd Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Orphanet J Rare Dis. 2019 Jul 5;14(1):167. doi: 10.1186/s13023-019-1133-2.
Wilson disease (WD) is a genetic disorder involving impaired copper metabolism, which presents with hepatic, neurological, and/or psychiatric manifestations. WD requires lifelong pharmacotherapy and treatment persistence may be problematic. We studied social characteristics, education, and work-related activities and how they are affected by WD symptoms and treatment persistence.
In a cross-sectional study, data on demographic characteristics, achieved education level, household and marital status, plus a primary source of income were collected from 202 Polish subjects (mean ± standard deviation age of 36.4 ± 9.9 years at assessment) with WD.
Overall, WD appeared to have a negative impact on achieved level of education and influenced the ability to work as compared with the general Polish population. Patients with neurological manifestations less often achieved upper-secondary/post-secondary or higher education compared with those with hepatic manifestations (65.5% vs. 83.6%; p = 0.003). They also significantly less frequently stated salary (19.6% vs. 56.2%; p < 0.0001) as the primary income and more often were on disability pension (53.3% vs. 26.0%; p = 0.0003). The percentage of married patients with WD appeared lower than in the general population (47.0% vs. 54.6%), although the difference was not significant (p = 0.2). The 27.6% of patients who were non-persistent with WD treatment less frequently achieved upper/post-secondary or higher education compared with persistent patients (66.0% vs. 76.3%; NS) and their primary source of outcome was significantly less often a salary (18.9% vs. 40.3%; p = 0.001).
Neurological manifestations had an adverse effect on education level and work ability. Treatment non-persistence had a further negative impact regardless of the disease form. Patients with WD should receive appropriate treatment, with the need for persistence emphasized and monitored to avoid a detrimental effect on their lives.
威尔逊病(WD)是一种遗传性铜代谢紊乱疾病,可导致肝脏、神经和/或精神症状。WD 需要终身药物治疗,治疗的持续性可能是个问题。我们研究了社会特征、教育和与工作相关的活动,以及它们如何受到 WD 症状和治疗持续性的影响。
在一项横断面研究中,我们从 202 名波兰 WD 患者(评估时的平均年龄为 36.4±9.9 岁)收集了人口统计学特征、已完成的教育水平、家庭和婚姻状况以及主要收入来源的数据。
总体而言,与一般波兰人群相比,WD 似乎对已完成的教育水平产生负面影响,并影响工作能力。与肝表现相比,神经表现的患者获得高中后/高等教育的比例较低(65.5%比 83.6%;p=0.003)。他们作为主要收入来源的工资(19.6%比 56.2%;p<0.0001)也明显较少,而更多的人领取残疾抚恤金(53.3%比 26.0%;p=0.0003)。WD 患者的已婚比例似乎低于一般人群(47.0%比 54.6%),尽管差异无统计学意义(p=0.2)。27.6%的 WD 治疗非持续性患者与持续性患者相比,获得高中后/高等教育的比例较低(66.0%比 76.3%;NS),其主要收入来源明显较少是工资(18.9%比 40.3%;p=0.001)。
神经表现对教育水平和工作能力有不良影响。无论疾病形式如何,治疗非持续性都有进一步的负面影响。WD 患者应接受适当的治疗,强调并监测治疗的持续性,以避免对其生活造成不利影响。